Pharmacyclics, an AbbVie Company Email Format

Pharmaceutical ManufacturingCalifornia, United States501-1000 Employees

Pharmacyclics develops and commercializes therapies aimed at extending and improving the lives of cancer patients and addressing significant unmet medical needs in oncology. The company operates as a wholly owned subsidiary of AbbVie, a global biopharmaceutical company, and is based in Sunnyvale, California. Within AbbVie’s oncology strategy, Pharmacyclics contributes to a broad portfolio and pipeline supported by research and development across multiple cancer types. 

A sizable team of researchers, clinicians, and professionals in the San Francisco Bay Area collaborates to translate scientific advances into novel cancer treatments, drawing on expertise across immuno-oncology and related scientific fields. The organization functions as part of AbbVie, leveraging the wider company’s resources while focusing on oncology advancement. In 2025, Pharmacyclics received the Prix Galien award for pharmaceutical research and development.

Get verified Pharmacyclics, an AbbVie Company emails free

Company overview Employee directory